tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

PVLA Stock Latest News

BUY Rating on Palvella Therapeutics: De-Risked SELVA Phase 3 Design Positions QTORIN Rapamycin for First-in-Class MLM Approval and Compelling Risk–Reward
RatingsBUY Rating on Palvella Therapeutics: De-Risked SELVA Phase 3 Design Positions QTORIN Rapamycin for First-in-Class MLM Approval and Compelling Risk–Reward
2d ago
PVLA
Palvella Therapeutics issues update, 2026 outlook
PremiumThe Fly
Palvella Therapeutics issues update, 2026 outlook
2d ago
PVLA
Wayfair upgraded, Instacart initiated: Wall Street’s top analyst calls
PremiumThe Fly
Wayfair upgraded, Instacart initiated: Wall Street’s top analyst calls
4d ago
W
HSY
Palvella Therapeutics appoints Vimal Patel as SVP, medical affairs
PremiumThe Fly
Palvella Therapeutics appoints Vimal Patel as SVP, medical affairs
4d ago
INCY
PVLA
Palvella Therapeutics initiated with an Outperform at Mizuho
PremiumThe Fly
Palvella Therapeutics initiated with an Outperform at Mizuho
4d ago
PVLA
Palvella Therapeutics price target raised to $133 from $97 at TD Cowen
PremiumThe FlyPalvella Therapeutics price target raised to $133 from $97 at TD Cowen
26d ago
PVLA
Palvella Therapeutics granted FDA Fast Track Designation to QTORIN
Premium
The Fly
Palvella Therapeutics granted FDA Fast Track Designation to QTORIN
26d ago
PVLA
Palvella Therapeutics price target raised to $204 from $148 at Canaccord
Premium
The Fly
Palvella Therapeutics price target raised to $204 from $148 at Canaccord
26d ago
PVLA
Buy Rating Affirmed for Palvella Therapeutics Following Promising Phase 2 TOIVA Trial Results
PremiumRatings
Buy Rating Affirmed for Palvella Therapeutics Following Promising Phase 2 TOIVA Trial Results
27d ago
PVLA
Palvella Therapeutics price target raised to $174 from $110 at Chardan
PremiumThe Fly
Palvella Therapeutics price target raised to $174 from $110 at Chardan
27d ago
PVLA
Palvella Therapeutics price target raised to $190 from $105 at Truist
PremiumThe Fly
Palvella Therapeutics price target raised to $190 from $105 at Truist
27d ago
PVLA
Promising Clinical Data and Market Potential Drive Buy Rating for Palvella Therapeutics’ QTORIN Rapamycin
PremiumRatings
Promising Clinical Data and Market Potential Drive Buy Rating for Palvella Therapeutics’ QTORIN Rapamycin
27d ago
PVLA
Palvella Therapeutics price target raised to $200 from $190 at H.C. Wainwright
PremiumThe FlyPalvella Therapeutics price target raised to $200 from $190 at H.C. Wainwright
27d ago
PVLA
Palvella price target raised to $210 from $200 at Cantor Fitzgerald
Premium
The Fly
Palvella price target raised to $210 from $200 at Cantor Fitzgerald
27d ago
PVLA
Palvella Therapeutics price target raised to $200 from $120 at Oppenheimer
Premium
The Fly
Palvella Therapeutics price target raised to $200 from $120 at Oppenheimer
27d ago
PVLA
Palvella Therapeutics price target raised to $212 from $122 at Lucid Capital
PremiumThe Fly
Palvella Therapeutics price target raised to $212 from $122 at Lucid Capital
27d ago
PVLA
Palvella Therapeutics Reports Positive Phase 2 Study Results
PremiumCompany Announcements
Palvella Therapeutics Reports Positive Phase 2 Study Results
27d ago
8K
PVLA
Palvella Therapeutics announces topline results from Phase 2 TOIVA trial
PremiumThe Fly
Palvella Therapeutics announces topline results from Phase 2 TOIVA trial
27d ago
PVLA
Positive Buy Rating for Palvella Therapeutics Driven by Promising Developments in DSAP Treatment
PremiumRatings
Positive Buy Rating for Palvella Therapeutics Driven by Promising Developments in DSAP Treatment
1M ago
PVLA
Palvella Therapeutics: Promising Biopharmaceutical Growth with QTORIN Platform Advancements
PremiumRatingsPalvella Therapeutics: Promising Biopharmaceutical Growth with QTORIN Platform Advancements
1M ago
PVLA
Palvella Therapeutics initiated with a Buy at BTIG
Premium
The Fly
Palvella Therapeutics initiated with a Buy at BTIG
1M ago
PVLA
Palvella Therapeutics initiated with a Buy at Clear Street
Premium
The Fly
Palvella Therapeutics initiated with a Buy at Clear Street
1M ago
PVLA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >